Business Wire (May 9, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
577 people get MDGN articles and Market Currents by email alert.
Get email alerts on MDGN »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 18, 2013)
-
Business Wire (Mar 26, 2013)
-
Business Wire (Mar 15, 2013)
-
Business Wire (Mar 14, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Feb 14, 2013)
-
Business Wire (Feb 8, 2013)
-
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 4, 2013)
-
Business Wire (Dec 6, 2012)
-
Business Wire (Nov 28, 2012)
-
Business Wire (Nov 14, 2012)
-
To learn more about Seeking Alpha Pro, click here.
There are no Transcripts on MDGN.
-
Business Wire (May 9, 2013)
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 18, 2013)
-
Business Wire (Mar 26, 2013)
-
Business Wire (Mar 15, 2013)
-
Business Wire (Mar 14, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Feb 14, 2013)
-
Business Wire (Feb 8, 2013)
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 4, 2013)
-
Business Wire (Dec 6, 2012)
-
Business Wire (Nov 28, 2012)
-
Business Wire (Nov 14, 2012)
-
Business Wire (Oct 16, 2012)
MDGN vs. ETF Alternatives
Company Description
Currently, there's no company description for MDGN.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Friday, February 8, 11:40 AM Medgenics (MDGN -7.3%) slips after pricing its offering of company stock and warrants at $5.25, near current levels. The company says it's bundling the shares and warrants together, with each unit sold at $5.25 consisting of one share of common stock and a warrant to purchase one-half of a share at an initial exercise price of $6.78. The medical technology and therapeutics company said it plans to sell 5.6M shares of stock in order to raise around $29.4M. Maxim Group is acting as sole book-running manager. 1 Comment [Healthcare, On the Move]
- Thursday, December 6, 2012, 1:36 PM Medgenics (MDGN -1.2%) says it's received a Notice of Allowance from the Japanese Patent and Trademark Office for key claims protecting the use of it's Infradure Biopump technology. The technology provides interferon therapy for the treatment of hepatitis B, C, and D. MDGN has already been granted patents covering core Biopump technology in the U.S. and in the EU. Comment! [Healthcare, On the Move]
- Wednesday, November 21, 2012, 1:18 PM Medgenics (MDGN +13.2%) gets a pop today after being granted a patent by the USPTO protecting the use of the company's Epodure Biopump technology for the treatment of anemia. The patent agency also allowed claims covering a similar method for delivery underlying it's Hemodure Biopump technology for sustained prophylactic treatment of hemophilia. MDGN's global portfolio now includes 36 patents issued, with 81 more pending. Comment! [Healthcare, On the Move]
- Wednesday, June 20, 2012, 3:08 PM Shares of Medgenics (MDGN +25%) soar after the company says its Infradure Biopump has received an Orphan Drug Designation from the FDA to treat hepatitis D. The designation carries multiple benefits, including the availability of grant money, certain tax credits and seven years of market exclusivity, as well as the possibility of an expedited regulatory process. Seeking Alpha contributor Ray Dirks says the designation makes it a prime takeout target. Comment! [Healthcare, On the Move]
-
- View all 5 replies
-
-
karatine14: what does it mean when it jumps down and up like that? are those actual trades people are making? or incorrect quote?
-
- View all 2 replies
-
-
-
- View all 3 replies
-
-
-
- View all 0 replies
-
prashAlpha
MDGN: 1st Subjects Enrolled In Ph-2a Clinical Trial Of EPODURE Biopumps To Treat Anemia In Patients With End-Stage Renal Disease On Dialysis - View all 0 replies
-
Scott Matusow
Didn't I suggest $MDGN when it was $7 a share? Closed all time high today at $15 a share.. I'm a luck box! Think I'll be wrong on $OMPI? - View all 17 replies
-
Scott Matusow: id have to look into ONCS. to be honest, I have been over focused in OMPI. Ya, I'm a luckbox, I take wild guesses and get lucky, believe me?
-
-
Scott Matusow
Don't expect a move like with $MDGN or " I will get rich overnight" the tech is exciting, no question, but remember, stocks are stocks - View all 0 replies
-
- View all 1 replies
-
-
Scott Matusow
I have a new feature article out on $MDGN, check it out at http://seekingalpha.com/a/elin - View all 0 replies
-
Scott Matusow
Short term target price opinion met on $MDGN this morning. Hit $9.65, 65 cents over my top target @ http://seekingalpha.com/a/ee5n #LUCKBOX - View all 4 replies
-
Scott Matusow: they absolutely do, and more so in the bio pharm segment than most because they show consistent PAST moves on catalysts.
-
LATEST REPLIES
-
- View all 5 replies
-
-
karatine14: what does it mean when it jumps down and up like that? are those actual trades people are making? or incorrect quote?
-
- View all 2 replies
-
-
-
- View all 3 replies
-
-
-
Scott Matusow
Didn't I suggest $MDGN when it was $7 a share? Closed all time high today at $15 a share.. I'm a luck box! Think I'll be wrong on $OMPI? - View all 17 replies
-
Scott Matusow: id have to look into ONCS. to be honest, I have been over focused in OMPI. Ya, I'm a luckbox, I take wild guesses and get lucky, believe me?
-
-
- View all 1 replies
-
-
Scott Matusow
Target nearly completed on $MDGN. said would see $9 on news, didnt think news today or this fast though! - View all 3 replies
-
Scott Matusow: u cant, its halted on Advisory committe recommendation approval.
-
garygallen: It came back early on pre-market @ about 42% higher than yesterdays close. MMs?, I backed off.
-
Scott Matusow
Short term target price opinion met on $MDGN this morning. Hit $9.65, 65 cents over my top target @ http://seekingalpha.com/a/ee5n #LUCKBOX - View all 4 replies
-
Scott Matusow: they absolutely do, and more so in the bio pharm segment than most because they show consistent PAST moves on catalysts.
-
-
Scott Matusow
News out on $MDGN, they got the orphan status and other stuff, check the news feeds, now watch it run! - View all 2 replies
-
drjbayer: Great News! Just barely got in on that. Those orphan status come quickly.
-
-
Scott Matusow
$MDGN moving back up, news was somewhat expected, but not during market hours, jeez! let's see what happens, interesting stuff. - View all 7 replies
-
-
-
Scott Matusow
Starting to think $MDGN could hit 10 the way its trading with a positive catalyst to bump it. - View all 5 replies
-
gafigal: Sadly, it moved too fast and me too slow. Missed that boat! Still, great call Scott!
-
-
Scott Matusow
$MDGN selling on news, heh, not what I thought, see, I am not always right, but company - View all 1 replies
-
-
Scott Matusow
My new article is out @ http://seekingalpha.com/a/ee5n $MDGN is my 'pop hard pick' I will be releasing a feature article on it tomorrow. - View all 6 replies
-
-